Medhub
Published on Medhub (https://www.medhub.se)

Home > Printer-friendly > LPA - Testing may improve

LPA - Testing may improve [1]

Lp(a) testing may improve CVC risk assessment in primary and secondary prevention settings

Figure is adapted from Nurmohamed et al. Eur J Prev Cardiol. 2022;29(5):769-776

Following Lp(a) testing 

  • One in three patients with very elevated Lp(a) levels* were reclassified into a higher primary prevention risk category
  • 50% of all patients with very elevated Lp(a) levels* were reclassified into a higher seconday prevention risk category

SCORE: Conroy et al. Eur Heart J 2003;24:987–1003; https://www.heartscore.org/en_GB [2] (Last accessed July 2024) SMART: Dorresteijn et al. Heart 2013;99:866–872; https://u-prevent.com/calculators/smartScore [3] (Last accessed July 2024); *> 99th percentile, mean Lp(a) of 460 nmol/L.


Source URL:https://www.medhub.se/lpa-testing-may-improve

Links
[1] https://www.medhub.se/lpa-testing-may-improve [2] https://www.heartscore.org/en_GB [3] https://u-prevent.com/calculators/smartScore